StockData
MENSNasdaqPharmaceutical Preparations

Jyong Biotech Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026
$1.93+0.09 (+4.89%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Jyong Biotech Ltd. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Jyong Biotech does not break out revenue by segment, region or product in the tagged data of its filings for this period type.